Prediction Model of Serum Lithium Concentrations

Area of Science:

• Pharmacokinetics
• Nephrology
• Clinical Chemistry

Background:

• Therapeutic drug monitoring (TDM) of lithium is crucial but hampered by the limited predictive accuracy of existing strategies.
• Accurate prediction of serum lithium concentrations is essential for optimizing patient outcomes and minimizing toxicity.

Purpose of the Study:

• To develop and validate a novel prediction model for serum lithium concentrations.
• To utilize creatinine clearance (CLcr)-based lithium clearance (Li-CL) for improved predictive accuracy in lithium therapy.

Main Methods:

• A pharmacokinetic model was developed using data from 82 subjects (131 samples).
• Lithium clearance (Li-CL) was calculated and normalized to creatinine clearance (CLcr).
• A 1-compartment model estimated serum lithium concentrations in 30 additional subjects.

Main Results:

• The developed model demonstrated high precision in predicting serum lithium concentrations.
• The mean absolute error in prediction was 0.13±0.09 mEq/L (95% CI: 0.10-0.16).
• The model utilized patient demographics, dosing regimens, and serum creatinine levels.

Conclusions:

• The proposed CLcr-based Li-CL model enables precise prediction of serum lithium concentrations from oral dosage.
• This model offers a valuable tool for enhancing the clinical application of lithium therapeutic drug monitoring.